Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
STX-721 is an irreversible inhibitor of EGFR with an exon 20 insertion (ex20ins) mutation.1 It selectively inhibits the proliferation of Ba/F3 cells expressing EGFR exon20 A769_V770 insASV and EGFR exon20 D770_N771 insSVD (IC50s = 5.4 and 5.8 nM, respectively) over those expressing wild-type EGFR (IC50 = 127.365 nM). STX-721 (50 mg/kg once per day) induces tumor regression in a mouse xenograft model using NCI H2073 non-small cell lung cancer (NSCLC) cells expressing EGFR exon20 D770_N771 insSVD.
WARNING This product is not for human or veterinary use.
1. Discovery of STX-